| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $4.71M | - | |
| Other | 21.6K | $1.34M | - | |
| Other | 15.4K | $957.6K | -5,538 | |
| Dir | 8.0K | $496.2K | - | |
| Dir | 8.0K | $496.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2015 | Robin Howard W58 | President &CEO | Sale+OE | 125,000 | $13.52 | $1,690,000.00 | -92.6% | |
| Nov 11, 2015 | Labrucherie Gil M84 | SVP &General Counsel | Sale+OE | 45,000 | $13.52 | $608,400.00 | -90.5% | |
| Nov 11, 2015 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sale+OE | 15,000 | $13.52 | $202,800.00 | -81.1% | |
| Oct 28, 2015 | Lingnau Lutz | Director | Sale+OE | 12,500 | $12.00 | $150,000.00 | -43.2% | |
| Oct 6, 2015 | Robin Howard W58 | President &CEO | Sale+OE | 125,000 | $10.99 | $1,373,750.00 | -92.6% | |
| Oct 6, 2015 | Labrucherie Gil M84 | SVP &General Counsel | Sale+OE | 45,000 | $10.99 | $494,550.00 | -90.5% | |
| Oct 6, 2015 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sale+OE | 15,000 | $10.99 | $164,850.00 | -81.1% | |
| Sep 23, 2015 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sale+OE | 10,000 | $13.04 | $130,400.00 | -74.1% | |
| Sep 23, 2015 | Robin Howard W58 | President &CEO | Sale+OE | 124,999 | $13.04 | $1,629,986.96 | -92.6% | |
| Sep 23, 2015 | Labrucherie Gil M84 | SVP &General Counsel | Sale+OE | 44,999 | $13.04 | $586,786.96 | -90.5% |